ADHERE-S (NIS Brilique)

Non-interventional Prospective Data Collection on Persistence and Adherence on Ticagrelor in ACS Adult Patients in Serbia

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03444012

Enrollment

269

Registered

2018-02-23

Start date

2018-03-05

Completion date

2019-08-13

Last updated

2020-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ACS (Acute Coronary Syndrome)

Brief summary

noninterventional study investigating persistence and adherence on ticagrelor in ACS patients in Serbia

Interventions

DRUGticagrelor 90 mg

persistence and adherence on ticagrelor in ACS patients

Study design

Observational model

OTHER

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* ≥ 18 years of age * diagnosed with ACS - STEMI or NSTEMI or unstable angina, invasively or non-invasively treated * Patients already on treatment with ticagrelor at least for 1 month and no longer than 3 months prior to study initiation. Enrolment in this study must not be trigger for ticagrelor initiation. * read and signed the Informed Consent Form

Exclusion criteria

Any contraindications as per approved SmPC of Brilique • Patients with life-threatening conditions which could disable patients to comply with scheduled visits and/or not able to fill in the patient questionnaires.

Design outcomes

Primary

Measure	Time frame
duration (number of days) on ticagrelor therapy in patients with acute coronary syndrome	1 year (12 months)

Countries

Serbia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026